Toxoplasmosis is a major and preventable cause of severe visual handicap and blindness in young people. Congenital toxoplasmosis, as well as toxoplasmosis in immunocompromised patients, is a serious, sometimes fatal disease. I 2 Toxoplasmic encephalitis has gained importance as a leading cause of AIDS related mortality.
Toxoplasma gondii, the aetiological agent of human and animal toxoplasmosis, is ubiquitous in nature. The organism is an obligate intracellular parasite and its definitive host is the cat. Oocysts, which are excreted in cat faeces, are highly resistant and may remain infective for more than 1 year. Usually only young cats are infected for a short period of time. The infected cat is not the primary source of infection for humans but is a very important cause of contamination of the environment (soil, fruit, and vegetables and thus other infected animals which become intermediate hosts).
Toxoplasma gondii is the most important protozoan cause of intraocular inflammation owing to its widespread distribution throughout the world, the frequency of ocular involvement, and the seriousness of the symptoms it may cause. Toxoplasmosis was first recognised in patients with congenital disease: in 1923 Janku' in Prague presented the first report on a boy who became blind at the age of 3 months and died ofhydrocephalus; a granulomatous inflammation of the eye with protozoa in the retina was found. 3 Wolf subsequently verified the aetiology by recovering the Toxoplasma and transmitting the infection to animals. 4 Retrospective analysis of specimens has demonstrated the disease in a large number of patients with neonatal encephalitis, thus emphasising the possibility of toxoplasmosis in such cases. 5 The major problem in diagnosing ocular toxoplasmosis in adults was the difficulty of establishing the presence of the parasite in ocular lesions. Helenor Wilder provided proof by demonstrating organisms with the morphological characteristics of Toxoplasma gondii in the eyes of patients with chorioretinitis, who had undergone enucleation because of blindness and pain. 6 Human infection may occur by either the congenital or the acquired route. Acquired disease usually develops after ingestion of oocysts or tissue cysts and almost all cases (in immunocompetent individuals) are asymptomatic. The prevalence of seropositivity due to a previous Toxoplasma infection varies among different populations, depending on eating habits, climate, etc. In the Netherlands the majority of the population has already been infected by the age of 40 years. 7 Congenital infection can occur when a pregnant woman becomes infected; during the parasitaemia, Toxoplasma crosses the placenta and invades the tissues of the developing fetus. The risk and severity of infection in the child depend on the time of gestation in which the mother acquires the infection.8 The severity of congenital infection is greatest when the disease is acquired during the early stages of pregnancy. The frequency of transmission to the fetus is highest during the third trimester, when contact between the maternal and fetal circulations is more likely to occur.8 Overall, about 40% of children of infected mothers will also become infected. Of these infected children only a small proportion will exhibit clinical symptoms directly after birth. However, long term follow up has shown that about 80% of these infected children will eventually develop neurological and/or ocular sequelae.111 Once maternal immunity has developed, it is believed that all subsequent fetuses will be protected against congenital toxoplasmosis. However, a case of repeated fetal infections acquired from the same mother with presumed chronic toxoplasmic endometritis has been reported. ' 21 The epidemiological pattern revealed a paucity of ocular lesions in young children and an increase in the prevalence of ocular lesions during adolescence, a phenomenon which has also been noted in congenital disease.9'0 Several hypotheses have been presented on the role of acquired toxoplasmosis in ocular disease, addressing the importance of infection at an early age, long term antigen exposure and the role of reinfections, strain differences between parasites, as well as genetic differences between hosts. Ocular disease, which is not common in such cases, may be atypical with such features as bilateral multifocal lesions. AIDS patients with (ocular) toxoplasmosis usually require continuous, lifelong treatment.2223 Toxoplasmic retinochoroiditis in AIDS is probably due to (reactivation of) acquired disease, although in some cases it may result from pre-existing congenital ocular lesions. 22 
Clinical manifestations
The ocular lesions primarily affect the retina. The hallmark of ocular toxoplasmosis is focal necrotising retinitis, ultimately resulting in characteristic atrophic scars. Old inactive atrophic scars sometimes help to establish the correct diagnosis of a former ocular disease, but such a finding does not present a therapeutic dilemma (Fig 1) . It is active retinitis which poses diagnostic and therapeutic problems. Funduscopy may be difficult because of the inflammatory reaction in the vitreous -the lesions resemble 'headlights in the fog' (Fig 2) . The active lesions may vary in size but are usually oval or circular. Frequently reactivation is situated adjacent to an old atrophic scar with hyperpigmentation along the borders, indicating an old infection (satellite formation; Fig  3) . During active inflammation the retina is thickened and cream-coloured due to necrosis and associated oedema. Overlying inflammatory cells and sometimes dense infiltrates are observed in the vitreous (Fig 4) . Retinal vasculitis and sometimes a haemorrhage may surround an active lesion ( Fig  4) . Fluorescein angiography demonstrates early masking with late fluorescence from the active lesion. Anterior uveitis, sometimes associated with granuloma formation and a secondary rise in intraocular pressure, may also be noted. This anterior segment reaction is thought to represent either an 'overspill' from the posterior segment or a secondary immunological reaction, but Toxoplasma has also been observed in the iris of a patient with AIDS.24
Ocular toxoplasmosis is a self-limiting disease (in patients with a normal immune system) and, without treatment, the inflammation gradually subsides and the lesion usually heals in 6-8 weeks. The healing process is indicated by decreased protuberance and sharper borders of the retinal lesion associated with the beginning of pigment clumping. The typical scar is atrophic with hyperpigmented borders, sometimes resembling a coloboma. A visual field defect corresponding to the interruption of the retinal fibre layer may ensue. In the event of treatment these scars may be atypical with a fragmentary aspect (Fig 5) . The characteristic picture of a juxtapapillary lesion (Jensen's retinitis, Fig 6) is well known and may cause an arcuate visual field defect, which may be symptomatic ifit involves an area which affects the ability to see objects close by. Sometimes papillitis with secondary optic atrophy develops.
Clinical presentation of ocular toxoplasmosis as multiple grey-white punctate lesions located deep in the retina has been described by Friedman and Knox. 25 Resolution of these lesions may leave a typical toxoplasmic scar.
The disease is bilateral in 40% of cases (however, in immunocompetent individuals it is almost never active simultaneously in both eyes); the finding of a typical scar in the contralateral eye may contribute to the diagnosis.
The most common symptoms ofpatients with toxoplasmic chorioretinitis are black floating spots in the affected eye. Blurred vision caused by inflammatory debris is common (Fig 4) . If the visual axis or macula is involved, vision may be severely reduced. Ocular pain and redness may occur when severe iridocyclitis is present.
The most important complication of ocular toxoplasmosis is permanent loss of visual acuity. When the lesion is peripheral, the prognosis is excellent. However, if the lesion is located near the macula, associated macular oedema may affect the central acuity. Finally, the retinal lesion may involve the macula directly, which causes definite loss of central visual acuity.
Other complications include subretinal and choroidal neovascularisation (Fig 7) 6 Histological studies have shown that in murine congenital ocular toxoplasmosis the inflammatory response is directed toward the photoreceptor layer of the retina and not to the Toxoplasma cysts, which could suggest an autoimmune mechanism for the retinal damage. 37 HLA typing of patients with ocular toxoplasmosis did not reveal an association with a specific phenotype, and no correlation was observed between any HLA phenotype and in vitro responsiveness to purified Toxoplasma antigen or bovine retinal S antigen. 38 One may conclude that the initiating events of toxoplasmic retinitis are not known nor has the role of immunological processes in the pathogenesis of tissue destruction in this infectious type of uveitis been established.
Diagnosis
Until serological tests were developed, the diagnosis of toxoplasmosis depended on histological examination and animal inoculation. In reality, the diagnosis of ocular toxoplasmosis has remained mainly clinical, despite the development of serological tests; it appeared that these tests were positive for a considerable percentage of the general population and are not necessarily indicative of ocular involvement.7 40 In the case of acute acquired toxoplasmosis, which rarely causes ocular disease, the antibody titres are usually very high, and therefore serology is indispensable for this diagnosis. The diagnosis ofociular toxoplasmosis may be very difficult. The conclusive diagnosis of active toxoplasmosis depends on the isolation of Toxoplasma from body fluids or tissues while the patient actually has the disease, but this is rarely possible in ocular disease. It has been reported that cryotherapy (as well as photocoagulation of the retinal lesions) can be of benefit since it decreases the number of recurrences. However the number of patients are too small to be able to draw definite conclusions. 7"77 In view of these findings it seems that an important means ofcontrolling ocular toxoplasmosis is prevention ofcongenital infection. This is achieved by preventing maternal infection during pregnancy. Induction of protective immunity against toxoplasmosis using purified parasite antigen (p30) vaccine has been achieved in mice and is an important step 
